Our results point at E2F1 as a regulatory factor modulating gemcitabine induced VMP1-mediated autophagy in human pancreatic cancer cells and mechanistically integrate the autophagic degradative process into the complex network of events involved in PDAC chemoresistance. This evidence concerns the gene E2F1 and pancreatic neoplasm.